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Abstract: 
Background: Cardiac anatomy and function adapt in response to chronic cardiac resynchronization 
therapy (CRT). The effects of these changes on the optimal left ventricle (LV) lead location and timing 
delay settings have yet to be fully explored.  
Objective: To predict the effects of chronic CRT on the optimal LV lead location and device timing 
settings over time. 
Methods: Biophysical computational cardiac models were generated for 3 patients, immediately post-
implant (ACUTE) and after at least 6 months of CRT (CHRONIC). Optimal LV pacing area and device 
settings were predicted by pacing the ACUTE and CHRONIC models across the LV epicardium (49 sites 
each) with a range of 9 pacing settings and simulating the acute hemodynamic response (AHR) of the 
heart.  
Results: There were statistically significant differences between the distribution of the AHR in the ACUTE 
and CHRONIC models (p<0.0005 in all cases). The site delivering the maximal AHR shifted location 
between the ACUTE and CHRONIC models but provided a negligible improvement (<2%). The majority of 
the acute optimal LV pacing regions (76-100%) and device settings (76-91%) remained optimal 
chronically.  
Conclusion: Optimization of the LV pacing location and device settings were important at the time of 
implant, with a reduced benefit over time, where the majority of the acute optimal LV pacing region and 
device settings remained optimal with chronic CRT.  
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Introduction: 1 
Cardiac resynchronization therapy (CRT) is an effective treatment for drug refractory patients with 2 
dyssynchronous heart failure, however 30% of patients fulfilling current CRT implant criteria do not 3 
respond1. CRT non-response is multifactorial and reflects underlying patient substrate, implantation 4 
issues including left ventricular (LV) pacing site location and post-implant programming with suboptimal 5 
atrioventricular delay (AVD) and/or interventricular delay (VVD) settings2.  6 
Optimal LV pacing location strategies have been proposed to maximize cardiac function at the time of 7 
implant, where the ideal LV site has been identified as being at the site of the latest mechanical3 or 8 
electrical activation4 and away from the apex and scarred regions of the heart5, 6. Optimizing AV/VVD, 9 
while holding the pacing location fixed, have shown improvements in the acute hemodynamic response 10 
(AHR) at the time of implant7, 8. 11 
The ability of AV/VVD optimization to partially compensate for suboptimal LV lead placement 12 
demonstrates the interdependence of these device settings9, 10. Despite this, routine optimization of the 13 
AVD/VVD settings concurrently with the LV lead location optimization is typically not performed. 14 
Currently there are no clinical guidelines for optimizing AV/VVD settings. Therefore a common strategy 15 
is to use the default device settings and optimize for the LV lead location at time of implant and only 16 
optimizing the AV/VVD for non-responders at a later stage2, 11, 12. 17 
The optimal AV/VVD settings and LV stimulation site have significant inter-individual variation. This 18 
inter-individual variability may be compounded by significant intra-individual variation within a single 19 
patient over time due to changes in the cardiac anatomy and function caused by sustained CRT. Due to 20 
dynamic changes in cardiac physiology and anatomy, whether it be positive (in responders) or negative 21 
(in non-responders), the optimal pacing location and device timings may change dynamically. Optimizing 22 
pacing location and timings as the heart remodels over time may therefore offer a strategy for 23 
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maximizing CRT response13, 14. Dynamically optimizing timing delays during the course of CRT treatment 24 
remains controversial, with some studies showing improvement15, 16, while others finding no 25 
improvements in clinical outcome with optimization after 3-6 months of CRT7, 17. Recent advances in 26 
multisite LV stimulation from multipolar leads in a single vein or multi-vein pacing now offer the 27 
potential to non-invasively and dynamically optimize both the timing and location of pacing following 28 
device implantation to maximize patient response18, 19. However, determining the best way to alter the 29 
pacing location and device timings remains a significant challenge.  30 
Biophysical models of a patient’s heart provide a framework for capturing patient physiology and 31 
pathology. Using models, the functional response of the heart can be simulated and thereby predict the 32 
optimal LV pacing location and the optimal AV/VVD timings. Modeling can be performed both to reflect 33 
the acute setting at implant and in the chronic setting following implantation after the heart has 34 
undergone LV reverse remodeling, with CRT associated changes in the geometry, electrophysiology20, 21, 35 
loading conditions and cardiac mechanics22, 23.  36 
We have previously modeled the acute effects of CRT in relation to the optimal LV pacing location and 37 
validated these findings with AHR from actual patients24, 25. The ability to create biophysical models to 38 
predict the optimal pacing site with chronic CRT following remodeling and the effects of AVD and VVD 39 
optimization is possible but has not previously been described, as this requires invasive data both at the 40 
time of implant and chronically following CRT, which is not routinely acquired in clinical practice. To 41 
perform this analysis we used biophysical modeling in a small number of patients who had uniquely 42 
undergone invasive electrical and hemodynamic measures both at implant and after at least six months 43 
following CRT. We hypothesized that as the heart remodeled with chronic CRT, the optimal LV pacing 44 
location and AV/VVD combination and the benefits of optimizing these parameters would change over 45 
time.  46 
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Methods:  47 
Data was acquired from 3 patients with standard indications for CRT, who had undergone both acute 48 
and chronic invasive hemodynamic pacing studies as part of dedicated research protocols26. Patients 49 
were male, aged 64±6 years with ischemic heart disease, 2D ejection fraction was 20±12% and all 50 
patients had left bundle branch block on the surface ECG with a mean QRS duration (QRSd) of 51 
151±25ms, with New York Heart Association (NYHA) class III symptoms at the time of implant. In all 52 
cases the LV lead was placed in the lateral or postero-lateral branches of the coronary sinus vein using a 53 
multipolar LV lead (Quartet St Jude Medical), while the right ventricle (RV) lead was placed in the RV 54 
apex.  55 
For each patient, the CRT clinical response (NYHA class, Minnesota Living with Heart Failure 56 
Questionnaire score, 6 minute walk distance) and the LV reverse remodeling response (percentage 57 
change in 2D cardiac echo LV end systolic volume (ESV)) were recorded within 3 months prior to implant 58 
and after at least 6 months of CRT for the 3 patients is summarized in Table 1. In contrast to the 59 
improvement in the LV response for cases 1 and 2, an improvement in the clinical measures was 60 
reported for cases 2 and 3 (Table 1). In previous work by Yu et. al., it was found that though there was a 61 
tendency for an improvement in the clinical response to be correlated with long term survival, this was 62 
not statistically significant27. A decrease of ≥10% LV ESV was found to be a strong predictor of the long-63 
term survival and lower heart failure events for patients27, and has been used to classify the 3 patient 64 
cases into responders (cases 1 and 2) and non-responders (case 3) in this study.  65 
All patients provided written informed consent for both procedures which were approved by the Local 66 
Research Ethics Committee. Patients underwent an acute hemodynamic pacing study at the time of CRT 67 
implant with a pressure wire (Radi wire, Radi Medical Systems, Uppsala, Sweden) placed into the LV 68 
cavity to measure the maximal change in pressure over time (dP/dtmax) with atrial and biventricular (BiV) 69 
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pacing. The relative improvement of dP/dtmax between atrial and BiV pacing was used to calculate the 70 
AHR of the patient to pacing (Table 2): 71 
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All patients underwent MRI imaging within 3 months prior to device implantation as a part of standard 72 
clinical practice. Segmentations of the 3D whole heart and contrast-enhanced MR images were used to 73 
personalize the cardiac anatomy and scar regions in the models prior to sustained pacing (ACUTE 74 
models)24, 25. The changes in the cardiac geometry after chronic CRT were represented in the models by 75 
deforming the ACUTE models to match segmentations from 2D and 3D echocardiography performed 76 
after sustained CRT (CHRONIC models) (see Supplement). 77 
After at least 6 months of CRT, a further invasive study was performed with pressure measurements and 78 
electro-anatomical mapping of the LV cavity, acquired using a pressure wire and a non-contact mapping 79 
array (EnSite Array Catheter, St Jude Medical, Minnetonka, MN, USA) placed in the LV, respectively26. X-80 
ray fluoroscopy images were acquired during the invasive studies to track the location of the pacing 81 
leads. X-ray MR image registration was used to determine the pacing locations in the model simulations 82 
28.  83 
In this study, the models used to investigate CRT focused on the isovolumetric contraction, systole and 84 
isovolumetric relaxation phases of the cardiac cycle, to simulate the phases of the cardiac cycle of 85 
interest and to reduce computational costs. Large deformation mechanics were simulated using 86 
Continuum Mechanics, Image analysis, Signal processing and System Identification (CMISS) software 87 
(www.cmiss.org).  88 
The fiber architecture was set to vary from apex to base and transmurally using a previously described, 89 
rule-based method derived from cadaveric and canine data24 (Supplement: Table 1). The 90 
Page 6 of 42Journal of Cardiovascular Electrophysiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
5 
 
electrophysiology of the heart was simulated using the Cardiac Arrhythmia Research Package (CARP)29. 91 
The electrical activation of the heart was simulated by pacing the heart at the intrinsic or paced 92 
activation sites and fitting the conductivity parameters to the QRSd determined from 12 lead ECG. The 93 
geometry of the LV endocardium in the model at the CHRONIC stage was derived from 3D cardiac echo 94 
images, while the EnSite system maps the LV endocardial surface separately (Figure 1). The model 95 
simulations of the electrical activation were qualitatively compared against the clinical measurements, 96 
as currently there is no standard method for mapping between the LV endocardial surfaces derived from 97 
medical images and the Ensite system. To quantitatively validate the model, we predicted activation 98 
times for additional protocols (RV or LV only pacing) and it was found that the electrical conductivity 99 
parameters led to an error between the model predicted and clinical QRSd of 7.1±3.1ms (see 100 
Supplement: Table 2).  101 
The passive and active mechanics parameters and the pressure boundary condition model parameters 102 
were fitted based on the pressure-volume curve (PV loop). The volume transients at the ACUTE and 103 
CHRONIC time points were acquired from semi-automatic tracking of the LV endocardial surface using 104 
TomTec software (www.tomtec.de) with ECG gated cine MR and 3D cardiac echo images, respectively. 105 
The volume transients were normalized with regard to the end diastolic volume of the LV. Volume 106 
transients were registered to the invasive pressure measurements using simultaneously recorded ECG to 107 
generate PV loops at ACUTE and CHRONIC time points, as described previously25.  108 
A 3 element Windkessel model was used to represent the systemic blood flow and pressure out of the 109 
ventricles. The Windkessel and passive mechanic parameters in each model were fitted to the PV loops 110 
for each patient at ACUTE and CHRONIC time points25. The active contraction of the heart was 111 
represented using a length dependent model24. The active parameters were fitted to both the PV loops 112 
and the AHR of the heart with atrial and BiV pacing for the ACUTE and CHRONIC models for the 3 cases 113 
(Figure 2). The function of the heart, as reproduced with the AHR for the ACUTE and CHRONIC studies, 114 
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show a good agreement between the measured and modeled AHR (Table 2). Epicardial and endocardial 115 
wall motion contours are overlaid in the cine MRI to validate the simulated motion of the heart 116 
throughout the modeled phases of the heart cycle as shown in Figure 3.  117 
Quantification of the size of the optimal pacing region 118 
Pacing sites across the LV free wall were simulated using the models to determine the relative roles of 119 
LV pacing location and timing settings on AHR with chronic CRT over time. Actual LV coronary sinus 120 
pacing is limited to sites accessible via the coronary branch anatomy, whereas in computer models 121 
activation can be simulated at all points across the myocardium. In each ACUTE and CHRONIC model, 49 122 
simulations were run, where the LV pacing site was varied to span the LV epicardium (Figure 1). Each LV 123 
pacing site was activated along with the RV lead pacing site and the intrinsic activation sites, for 9 124 
AV/VVD permutations. The AHR was evaluated across the LV epicardium and interpolated to provide a 125 
continuous estimate of AHR at all locations. The optimal pacing region was defined as the area within 126 
70% of the global maximal AHR as proposed previously by Helm et al30 and was plotted on the AHA 127 
model.  128 
AV/VVD optimization simulation 129 
The modeling framework focuses on the ventricles and does not explicitly represent the atria. The AVD 130 
is the time delay between when atrial pacing occurs to when the ventricles are paced. The intrinsic 131 
electrical activation of the heart from the atria passes through the atrio-ventricular node, where it then 132 
travels via the fast conducting Purkinje network to activate the ventricles. The effect of changing AVD 133 
was approximated by changing the timing of the intrinsic activation that is set by atrial pacing, and the 134 
delay to the ventricle pacing leads. A short AVD where the ventricle leads are activated early is modeled 135 
by the absence of any intrinsic activation. A fused AVD is modeled by simultaneous activation of the 136 
ventricle leads and intrinsic activation while a long AVD delay is modeled by ventricle lead activation 137 
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40ms after the intrinsic activation. Three VVDs were modeled with -20, 0 and +20ms with positive values 138 
for early RV pacing31. This gives 9 AVD/VVD permutations. 139 
The ACUTE and CHRONIC models were paced across the LV free wall (49 sites) with 9 different AV/VVD 140 
combinations giving 441 simulations per model (2646 simulations in total). In contrast to a sequential 141 
optimization, where the LV pacing location, AVD then VVD timing delays are successively optimized, the 142 
exhaustive search method we have taken calculates the global maximal AHR for each case for the ACUTE 143 
and CHRONIC models across all locations and timing combinations.  144 
Statistics 145 
For each case, ACUTE and CHRONIC models were used to simulate pacing at 9 device settings and 49 146 
locations across the LV free wall to predict the AHR. Values are reported as the mean ± standard 147 
deviation. Post-hoc comparisons of the 441 simulations of the AHR between the ACUTE and CHRONIC 148 
time points were made using paired t-tests for each patient case. P<0.05 was considered statistically 149 
significant. 150 
Results  151 
Biophysically based models of the heart were generated for the three patient cases at both the ACUTE 152 
and CHRONIC time points. Simulations of pacing at 49 different sites across the LV epicardium with 9 153 
different AV/VVD device settings were used to predict the AHR of the heart to pacing at the ACUTE and 154 
CHRONIC time points.  155 
Difference between ACUTE and CHRONIC models 156 
To determine if the optimal LV pacing location and the AV/VVD settings change with chronic CRT, in 157 
each patient case, a paired t-test was used to compare the AHR distribution over the LV free wall 158 
between the ACUTE and CHRONIC models. The mean±SD for the AHR across the LV free wall for the 9 159 
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timing variations for the ACUTE and CHRONIC models were: case 1: 32.9±18.2% and 18.0±7.7%; case 2: 160 
4.4±5.7% and 5.9±7.9%; case 3: 2.1±1.7% and 5.7±5.8%, respectively with p<0.0005 in all cases. 161 
Benefits of LV lead location optimization 162 
Figure 4 shows the optimal area and maximal AHR site for LV pacing for the ACUTE and CHRONIC 163 
models. Across all 3 cases, the majority of the optimal region from the ACUTE model remained within 164 
the CHRONIC optimal region. In case 2, the optimal pacing region in the ACUTE model lay entirely within 165 
that of the CHRONIC model. For case 1 and 3, the optimal pacing area shifted, predicting that if the 166 
pacing lead was within the ACUTE optimal region, then it had an 82% and 76% probability, respectively 167 
of remaining optimal after chronic CRT. The best single site for pacing the LV shifted in all cases after 168 
sustained pacing (Figure 4), however altering the pacing site from the maximal ACUTE to the maximal 169 
CHRONIC pacing location only improved the AHR by <2% for all cases (case 1: 0.4%, case 2: 1.3%, case 3: 170 
1.2%).  171 
Benefits of timing delay optimization 172 
Figure 5 shows the percentage of the 49 evaluated pacing locations that achieve an optimal response for 173 
different numbers of combinations of AV/VVD timings. In all 3 case studies, the predicted number of 174 
AV/VVD/pacing locations that delivered optimal AHR increased between the ACUTE and CHRONIC CRT 175 
models (20% to 26% for case 1; 3% to 10% for case 2; 8% to 18% for case 3). The majority of optimal 176 
AV/VVD settings in the ACUTE models are predicted to remain optimal chronically (case 1: 88%, case 2: 177 
91%, case 3: 76%) at the same LV pacing site.  178 
Discussion 179 
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ACUTE and CHRONIC biophysical models were generated for 3 case studies to predict the relative 180 
importance of LV lead location and AV/VVD optimization in the acute response of the heart immediately 181 
post-implant and after sustained CRT treatment.  182 
Our results are the first to model both acute and chronic response to CRT in humans and show that:  183 
1) The model replicates measured hemodynamic and electrical indices for both the ACUTE and 184 
CHRONIC time-points. 185 
2) Lead optimization and AV/VVD optimization at the time of implant were important in improving 186 
acute and chronic response. 187 
3) The models predicted that the benefits of AV/VVD and lead location optimization decreased 188 
over time with sustained pacing i.e. with chronic CRT there was less incremental benefit seen 189 
with AV/VVD or lead position optimization.  190 
Benefits of optimizing the LV lead location over time 191 
Acute optimization of the LV lead location is a recognized strategy for maximizing CRT response3-6. 192 
Optimizing the pacing location acutely using multisite pacing have shown improved AHR19, 32, however 193 
the ability to dynamically optimize pacing location post-implant with these new lead technologies has 194 
yet to be evaluated. At both acute and chronic time points, our models predicted distinct pacing regions 195 
that gave optimal AHR that covered most of the LV lateral free wall, consistent with acute animal 196 
studies30, clinical studies33 and clinical guidelines for CRT11. Our models predicted that the majority (76-197 
100%) of the ACUTE optimal pacing locations remain optimal in the CHRONIC case. The maximal AHR 198 
site shifted for all 3 cases as the heart remodeled (Figure 4) supporting post-implant lead location 199 
optimization, however the predicted improvement in AHR achieved by moving from the best ACUTE to 200 
the best CHRONIC pacing location in the CHRONIC model was small (<2%). The model indicates that it is 201 
more important to optimize the LV lead location at the time of implant, that this location is likely to be 202 
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in the LV lateral wall and that in the majority of locations this site will remain optimal as the heart 203 
remodels. 204 
Benefits of optimizing the AV/VVD over time 205 
Studies have shown the acute benefits of optimizing the AV/VVD7, 9 and our model simulations also 206 
reflected this, where optimizing the AV/VVD settings could improve the AHR (dependent on the default 207 
settings) at the ACUTE time point (Figure 5). The slope and the area under the curve for the ACUTE 208 
traces in Figure 5, reflect how beneficial optimizing between the simulated AV/VVD combinations would 209 
be. The greater the slope of the curve and the smaller the area under the curve is, the less overlap there 210 
is between the optimal areas of LV pacing for any of the 9 simulated combinations. In the chronic 211 
setting, we find that as the heart remodels the number of timing combinations that deliver an optimal 212 
response increases (shown as a rightward shift of all curves in Figure 5), consistent with previous studies 213 
that have not found a consistent benefit of dynamic AV/VVD optimization7, 17. In addition, our models 214 
predicted that an optimal AV/VVD/LV pacing site will likely remain optimal after sustained pacing 215 
indicating that it is more important to optimize for the AV/VVD at the time of implant.  216 
CRT non-responder 217 
In this study, response/non-response was classified based on an improvement of the LV response (≥10% 218 
decrease in the LV ESV27). Case 3 was classed as a non-responder based on the LV response deteriorating 219 
(LV ESV +36%). This is in keeping with the poor AHR acutely measured (0.3%) and predicted by the 220 
model (6.1%). However, after sustained pacing, the measured AHR increased (from 0.3% ACUTE to 221 
23.0% CHRONIC) (Table 2). An increase in the AHR in the non-responder seems counter-intuitive, 222 
however if we consider that if the LV response of the heart continues to deteriorate for case 3, then 223 
there is greater capacity for improvement with BiV pacing. In addition, we have shown that the models 224 
predicted that the site of maximal AHR shifts after sustained pacing (Figure 4). The predicted maximal 225 
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AHR site in the ACUTE model was further from the LV pacing lead than in the CHRONIC model (ACUTE: 226 
33mm; CHRONIC model: 15mm). The improvement in the proximity of the LV pacing lead to the ideal 227 
pacing site, in combination with the increased capacity of response to pacing could contribute to the 228 
observed increase of the AHR for this case.  229 
Limitations 230 
In this study we have only used 3 clinical case studies at two time points to generate our results, thus 231 
the conclusions drawn need to be taken in this context. The extensive clinical data required to build and 232 
validate biophysical models of patient’s hearts limit the expansion of this framework to large groups. We 233 
have chosen instead to run an in-depth study for these 3 patients, where 2646 simulations of different 234 
pacing locations and timing delays were run to explore the relative importance of LV lead and AV/VVD 235 
optimization over time.  236 
The range of AVD and VVD tested were limited to only 3 settings each, giving 9 combinations of device 237 
timing settings to be run over 49 different sites per model (441 simulations), to remain computationally 238 
tractable. Instead of optimizing for AVD at increments of 20ms over a wide range of AVD values as 239 
performed clinically9, 15, we chose to represent 3 scenarios for the AVD: a short AVD, a fused AVD and a 240 
long AVD. The VVD was set to be -20ms, 0ms, 20ms, as previous work found that the optimal VVD lies 241 
between ±20ms31. 242 
The model accounted for scar at the time of implant but we assumed the location, degree and 243 
properties of the scar at the ACUTE time remained constant in the CHRONIC model. Nor did we account 244 
for phrenic nerve stimulation. Changes in either of these conditions at a local pacing site could require 245 
the pacing location to be altered post-implant which could be enabled by multisite pacing lead 246 
technologies. 247 
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In this study, we optimized the LV pacing location and the AV/VVD settings using the AHR as a measure 248 
of the function of the heart. However, the link between the AHR and LV reverse remodeling remains 249 
controversial, with some studies finding no link34 while others have found a positive correlation between 250 
AHR and clinical outcome35. Other measures of acute improvement such as diastolic parameters and 251 
pressure volume loop have also been proposed, however they have yet to be linked to long term clinical 252 
response1, 22.  253 
Clinical relevance 254 
The heart anatomy and physiology dynamically remodels in response to CRT. We have generated 255 
biophysical patient-specific models to predict how these changes affect the optimal CRT lead pacing 256 
location and device timings. We find that there is diminished benefit in post-implant optimization of the 257 
pacing location or timings as the heart reverse remodels with the majority of settings remaining optimal 258 
as the heart responds to CRT. This emphasizes the importance of ensuring good lead position and 259 
optimized device settings at the time of implant. 260 
Conclusion 261 
In this study, patient-specific biophysical models were used as a framework to predict the optimal LV 262 
pacing location and the effects of AV/VVD optimization immediately post-implant and after at least 6 263 
months of CRT for 3 case studies. The models predict that although the optimal pacing region can shift, 264 
the majority of the optimal pacing sites remain in the LV lateral wall. The models predict that 265 
optimization of lead position and AV/VVD optimization are more beneficial at the time of implant than 266 
after sustained CRT pacing.  267 
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(a) Atrial pacing (b) BiV pacing with the 
clinical LV lead pacing site 
(c) Simulated BiV pacing 
with LV lead at 1 (white) of 
49 tested sites (blue) across 
the LV free wall  
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Figure 1: Top row: Clinical measurements of the LV endocardium electrical activation were taken using 
an ENSITE balloon catheter for case 2 with (a) Atrial pacing and (b) Biventricular (BiV) pacing. Middle 
row: The model parameters were fitted to the electrical activation of the heart with (a) Atrial or (b) BiV 
pacing. (c) The models were then used to simulate the electrical activation of the heart at a range of LV 
epicardium sites. Bottom row: The simulated activation wave on the LV endocardium was projected onto 
the 17 segment AHA map for the different scenarios.  
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Figure 2: Clinical (blue) and simulated (orange) pressure volume loops for the 3 patient cases before 
(ACUTE) and after at least 6 months of CRT treatment (CHRONIC). 
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Figure 3: The motion of the cardiac models during the cardiac cycle was validated against cine MR 
images. 
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Figure 4: The area where any 1 of the 9 combinations of AV/VVD timings would give an optimal 
response is shown (ACUTE: grey with solid outline; CHRONIC: brown with dashed outline). Areas of no 
overlap between the optimal regions for CHRONIC and ACUTE models are shown as striped. Regions in 
the CHRONIC models where all 9 of the AV/VVD combinations would give an optimal response are 
shown as yellow (dotted outline) for cases 1 and 3. There were no such regions in the ACUTE models and 
the CHRONIC model for case 2. The locations of the multipolar LV lead (blue), RV lead (red) and scar 
(green) are shown for all cases. The location of the maximal response for any of the 9 AV/VVD timings is 
shown as stars (ACUTE: grey; CHRONIC: brown). 
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Figure 5: The LV free wall was paced and the AHR was simulated at 49 locations with 9 AV/VVD setting in 
the ACUTE and CHRONIC time points for each case. The optimal LV pacing regions were defined as the 
LV sites within 70% of the global maximal AHR. The percentage of the 49 sites on the LV free wall which 
gives an optimal response for pacing with 1-9 of the simulated AV/VVD timing settings for the ACUTE 
and CHRONIC models are shown for the 3 cases. 
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Table 1: Clinical response (2D echo end systolic volume (ESV) change; New York Heart Association 
functional classification (NYHA class); Minnesota Living with Heart Failure Questionnaire (HF) score; 
and 6 minute walk distance) for the three patient cases within 3 months prior to device implantation 
(ACUTE) and after at least six months of sustained pacing (CHRONIC) were used to classify patients as 
either responders or non-responders to cardiac resynchronization therapy (CRT).    
Case Time 
ESV change NYHA class HF score 6 min walk 
distance 
Responder? 
Case 1 
ACUTE -67% III 45 Unchanged Y 
CHRONIC III 55   
Case 2 
ACUTE -11% III 36 280m Y 
CHRONIC I 26 370m  
Case 3 
ACUTE +36% III 64 505m N 
CHRONIC I 4 546m  
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Table 2: The clinical functional response of the patient to baseline (AAI) and biventricular (DDD-BiV) 
pacing was recorded at time of implant (ACUTE) and after at least six months of sustained pacing 
(CHRONIC). The pacing lead locations were mapped onto personalized biophysically based models of 
the heart for three patients. The heart models were used to simulate AAI and DDD-BiV pacing at the 
ACUTE and CHRONIC points. The acute hemodynamic response (AHR) of the heart to pacing was 
calculated as the relative change in the maximal change in left ventricular pressure over time 
between DDD-BiV and AAI pacing. The simulated AHR shows good agreement with the clinical AHR 
at both the ACUTE and CHRONIC time points. 
Case Time Clinical AHR Simulated AHR 
Case 1 
ACUTE 34.2% 30.1% 
CHRONIC 18.9% 18.1% 
Case 2 
ACUTE 17.8% 16.1% 
CHRONIC 19.2% 19.7% 
Case 3 
ACUTE 0.3% 6.1% 
CHRONIC 23.0%  20.5%    
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Biophysical Modeling to Determine the Optimization of Left Ventricular Pacing Site and 1 
Atrioventricular and Interventricular Delays in the Acute and Chronic Phase of Cardiac 2 
Resynchronization Therapy. 3 
SUPPLEMENTAL MATERIAL 4 
Further details of the clinical data acquisition, model personalization, and validation are given in this 5 
supplement.  6 
The study aimed to investigate the differences in the relative importance of the pacing location and 7 
device settings as the heart remodels over time with cardiac resynchronization therapy (CRT). 8 
Biophysically based computer models of the heart were used to simulate the contraction of the heart 9 
when it was paced at different locations across the LV epicardium and with varied device settings. In 10 
contrast to previous work (where a full description of the modeling framework is given) 
1, 2
 in this study 11 
two models of the heart were developed for each patient, representing the state of the heart both 12 
before and after CRT remodeling.  13 
Clinical data:  14 
Clinical data from 3 patients were acquired at two different time points: prior to/immediately post 15 
implant of the CRT device (ACUTE) and after at least 6 months of sustained CRT (CHRONIC) with fully 16 
informed written consent as per protocols approved by the local ethics committee. The models were 17 
personalized to each patient, with the pressure boundary conditions, geometry, mechanics, and 18 
electrical activation parameters fitted and validated from clinical data at the ACUTE and CHRONIC time 19 
points.  20 
Within 3 months prior to CRT implant (ACUTE), MR images were acquired using a 1.5T Philips Achieva 21 
system and steady-state free procession (SSFP) images were acquired of the 3D whole heart at the end 22 
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diastolic phase of the cardiac cycle (0.8 x 0.8 x 1mm). 2D short axis cine SSFP (1.4x1.4x10mm, 30 cardiac 23 
phases) and Gadolinium late-enhancement (1.25x1.25x10mm) breath-hold scans were also acquired. 24 
At initial implant (ACUTE), bilateral femoral access was used to place pacing catheters in the heart at the 25 
right ventricular (RV) apex, high right atria and left ventricle (LV). The LV was paced via the coronary 26 
sinus with a quadripolar catheter (Quartet St Jude Medical). The LV endocardial pressure changes were 27 
measured with a high fidelity wire pressure wire (Radi wire, Radi Medical Systems, Uppsala, Sweden) in 28 
the LV cavity. The heart was paced with the following protocol: at the high right atria for the baseline 29 
setting, RV-only, LV-only, or with simultaneous biventricular pacing (BiV) at 5-10 beats above the 30 
intrinsic heart rate with AVD 100ms and VVD 0ms where appropriate. The heart was paced at the high 31 
right atria, in between each of the other paced protocols and the pressure in the LV was recorded 20s 32 
after any change in pacing setting to ensure hemodynamic stability. As part of standard clinical practice, 33 
X-ray fluoroscopy images of the heart were acquired to track the location of the catheters during the 34 
procedure.  35 
After at least six months of sustained pacing (CHRONIC), pressure measurements were repeated with 36 
the same pacing protocol to determine the effects of sustained pacing. A non-contact mapping array 37 
(EnSite Array Catheter, St Jude Medical, Minnetonka, MN, USA) was also passed into the LV cavity to 38 
reconstruct the LV endocardial potential. As above, X-ray fluoroscopy images were also acquired and the 39 
invasive electroanatomical maps were aligned to the MRI data using the XMR registration technique 40 
developed by Rhode et al. 
3
. In addition 12 lead ECGs, real time 3D echocardiograms and 2-chamber, 3-41 
chamber, and 4-chamber 2D cardiac echos were acquired at both time points.  42 
 43 
 44 
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Geometric fitting:  45 
The geometry of the heart has been found to change with CRT treatment either positively (reverse 46 
remodeling) or negatively (continued deterioration with non-response to treatment)
4
. To personalize 47 
the geometry of the models to each patient, meshes were fit to medical images of the heart acquired 48 
from 3 patients before (ACUTE models) and after sustained CRT (CHRONIC models).  49 
ACUTE geometry 50 
Cardiac MR images were acquired as a part of standard clinical practice. SSFP MR images of the 3D 51 
whole heart at end diastole were segmented using Philips Model Based Segmentation Framework to 52 
generate binary masks of the ventricles
5
. Cubic Hermite meshes (144 elements, 228 or 231 nodes, C
1
 53 
continuous) were then fitted to the ventricle segmentations for each patient (ACUTE models) with a 54 
mean RMS error of <1mm
6
. Late Gadolinium enhancement MR images were used to identify regions of 55 
myocardial infarction, which were then mapped to the ACUTE models.  56 
Fiber structure 57 
Tissue microstructure orientation was described using a rule based fiber distribution motivated by 58 
canine
7-9
 and human
10
 studies that varied transmurally, in the apex-base direction, and between the left 59 
and right ventricle as shown below in Table 1: 60 
 61 
 62 
 63 
 64 
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Table 1. The fiber orientations in the models were defined using a rule-based method which varies the 65 
fiber and sheet angles of between the right ventricle (RV) and left ventricle (LV), through the 66 
endocardium (Endo) to the epicardium (epi), and from apex to base. The septum is between the right 67 
and left ventricles and thus there is no epicardium surface to be defined. 68 
Region Sheet angle  Fiber angle 
Endo Mid Epi Endo Mid Epi 
LV free wall base 0° 30° -40° 60° 0° -60°  
LV free wall apex   -20° -20° 15° 83° 24° -35° 
LV septum base 0° 0 n/a 60° 0 n/a 
LV septum apex 20° 10 n/a 83° 11.5 n/a 
RV free wall base 0° -20 -40° 60° 0 -60° 
RV free wall apex -20° -2.5 15° 60° -12.5 -35° 
RV septum base 0° 0 n/a -60° 0 n/a 
RV septum apex 0° 10 n/a -60° 11.5 n/a 
 69 
CHRONIC geometry 70 
Due to the implantation of the CRT device, MRI was not performed on the patient post-implant and 71 
instead 2D and 3D cardiac echo images were used to define the geometry of the heart after sustained 72 
CRT. Real time 3D cardiac echo images of the LV endocardium at end diastole were segmented using 73 
TomTec software (www.tomtec.de). The LV epicardium was not consistently captured in the 3D cardiac 74 
echo images, so 2D cardiac echo images (2-chamber, 3-chamber, and 4-chamber) were used to provide 75 
an estimate of the thickness of the LV. The biventricular ACUTE mesh was then warped to fit the new 76 
dimensions of the LV. The cardiac echo window similarly did not consistently capture the RV, therefore 77 
in the absence of clinical data describing the change in the RV with sustained treatment, the RV wall 78 
thickness and RV cavity were assumed to be unchanged from the ACUTE time point. The scar and fiber 79 
orientation in the CHRONIC models were mapped from the ACUTE meshes 
1, 2
.  80 
Mechanics fitting:   81 
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The heart deforms substantially throughout the cardiac cycle and to simulate the large deformation 82 
mechanics Continuum Mechanics, Image analysis, Signal processing and System Identification (CMISS) 83 
software (www.cmiss.org) was used.  84 
The passive and active mechanics parameters and the pressure boundary condition model parameters 85 
were fitted based on the pressure-volume curve (PV loop). Invasive pressure data was acquired at both 86 
the ACUTE and CHRONIC time points as previously described in Shetty et. al. 
11
. Short axis SSFP cine MR 87 
images were acquired at the ACUTE time point. Volume transients at the ACUTE time point were 88 
obtained from semi-automatic segmentations and tracking of the LV endocardium in the cine MR 89 
images by clinical experts using TomTec software. After CRT implant (CHRONIC), patients can no longer 90 
be imaged with MRI scanners, and therefore the volumetric transient of the left ventricle after sustained 91 
pacing were obtained from the segmentation and tracking of the LV endocardium throughout the 92 
cardiac cycle in 3D cardiac echo images by clinical experts using TomTec software. The volume was 93 
normalized to the end diastolic volume of the LV at each time point. The normalized volume and 94 
pressure data were then synchronized using the ECG recorded during the pressure or volume data 95 
acquisition to generate a PV loop 
1
, which was then used to constrain the model parameters.  96 
Passive mechanics 97 
As described in previous work 
1, 2
, passive material properties of viable cardiac tissue were modeled 98 
using a transversely isotropic hyperelastic constitutive law 
12
:  99 
 =           (1) 100 
 = 	

 + 0.5	 + 	 + 2	 + 0.5	
 + 	
,    (2) 101 
where Eff, Ess and Enn are the Green strain aligned with the fiber, sheet and sheet normal orientations, 102 
Ens, Efn and Efs are the corresponding Green shear strains. The passive material properties of the 103 
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ventricles, C1 and α were fit to the PV loop during atrial contraction when the ventricles were assumed 104 
to be quiescent.  105 
Scarred regions in the heart were assumed to be isotropic which required a reformulation of Eq.2 so 106 
that:  107 
 = 	

 + 	 + 	 + 	 + 	
 + 	
                                                         (3) 108 
A five-fold increase in α and doubled C1, with respect to the viable tissue, was used to approximate the 109 
increased stiffness due to the higher density of collagen in scarred tissue as observed in animal studies
13
.  110 
Pressure boundary conditions 111 
The pressure boundary conditions representing the systemic circulation were simulated with a 3-112 
element Windkessel model, where the change in flow is given by 
2
: 113 

 =   +  −  −   ,        (4) 114 
where U is the flow rate, C and R are the systemic compliance and resistance, respectively, Z is the aortic 115 
resistance and P is the LV pressure. The values for C, R and Z in the right ventricle were set to 4.5, 0.125 116 
and 0.35 times the left ventricle values based on prior experimental data 
14-16
.  117 
Active mechanics  118 
A phenomenological length dependent active tension model, based a simplification of previous work 119 
done by Kerckoffs et al.
17
 was used to represent the active material properties of the model 
2
:  120 
 = !"#ℎ"%&' − "()         (5) 121 
!* = !*+ + ",&1 −  )         (6) 122 
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./ = 0.+ !"#ℎ 

1 !"#ℎ 23456  0 < ! < !8/90 :;     (7) 123 
where a6 corresponds to the length degree of length dependence, a7 corresponds to the length where 124 
no active tension is generated, a4 is the scalar of length dependent activation, tr0 is the baseline 125 
activation time constant, td is the relaxation time constant, tmax is the duration of tension generation, λ is 126 
the stretch in the fiber direction, Ta is the active tension, tr regulates the rise time of the tension transit, 127 
φ is the nonlinear length dependent function and To is the peak isometric tension. The model of active 128 
tension was fitted to the isovolumetric contraction, systolic, and isovolumetric relaxation phases of the 129 
PV loop and the acute hemodynamic response (AHR) through successive parameter sweeps with Latin 130 
hypercube sampling.  131 
Electrophysiology fitting 132 
The electrophysiology of the heart was modeled using monodomain simplification of the bidomain 133 
equations:  134 
8 <2 + =>? = ∇ ∙ B8∇C8        (8) 135 
where Cm is the membrane capacitance, Vm is the transmembrane potential, Iion is transmembrane 136 
current, and Dm is the transversely isotropic conductivity tensor. The transmembrane current (Iion) was 137 
simulated using a detailed biophysically-based human cell model by ten Tussher
18
. The electrophysiology 138 
of the mesh was then solved using the Cardiac Arrhythmia Research Package (CARP)
19
, on high 139 
resolution, irregular, linear tetrahedral meshes (19-44 million vertices, 145-260 million elements, mean 140 
edge length 250µm), which were derived from the cubic Hermite ACUTE and CHRONIC geometry 141 
meshes. The associated fiber and scarred regions from the cubic Hermite meshes were mapped to the 142 
electrophysiology meshes 
1, 2
.  143 
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ACUTE electrophysiology 144 
To model the spread of electrical activation across the electrophysiology meshes, the location of the 145 
stimulation sites were defined. X-ray fluoroscopy images acquired during the CRT device implantation 146 
were registered against MR segmentation of the heart to identify the locations of the pacing leads 
20
, 147 
which were then mapped onto the ACUTE and CHRONIC models.  148 
To fit the conductivity in the electrophysiology models, ECG data was recorded at both time points and 149 
the recorded QRS duration (QRSd) was taken to represent the time taken for the electrical activation to 150 
spread across both ventricles. In all cases, the QRSd data was available for atrial pacing at the ACUTE 151 
time point. Atrial pacing was simulated in the models and the ACUTE model conductivities were fit using 152 
the measured QRSd for atrial pacing.  153 
CHRONIC electrophysiology 154 
The location of the RV and LV intrinsic activation sites were based on the activation maps recorded by 155 
Durrer et. al.
21
 and EnSite electro-anatomical maps at the CHRONIC time point 
2
, respectively. In the 156 
absence of this data at the ACUTE time point, it was assumed that the intrinsic activation sites would 157 
remain at the same relative locations in the mesh, so the intrinsic activation sites from the CHRONIC 158 
meshes were mapped onto the ACUTE meshes.  159 
At the CHRONIC time point, QRSd data was available for cases 2 and 3, when the heart was paced with 160 
atrial, LV only, RV only and BiV pacing. For case 1, only BiV pacing QRSd data was measured. The 161 
conductivity of the ACUTE and CHRONIC models were fitted using one pacing protocol (atrial pacing 162 
where possible or with BiV pacing). The simulated spread of electrical activation across the LV 163 
endocardium in the model was qualitatively compared against the endocardial calculated Ensite map
1
. A 164 
qualitative comparison was carried out as the Ensite system derives the endocardial surface separate 165 
from the MR images as shown in Figure 1 and mapping between these two geometries would inevitably 166 
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introduce errors in the fit. The electrophysiology of the models were quantitatively validated using 167 
clinical data acquired when the heart was paced with different settings at the CHRONIC time point (BiV, 168 
RV, LV) for cases 2 and 3. The mean error for the QRSd between the models and clinical data for cases 2 169 
and 3 was 7.1 ± 3.1ms in the CHRONIC stage (Table 2).  170 
(A)   (B)  171 
Figure 1. The spread of electrical activation across the LV endocardium surface from (A) the Ensite system and 172 
(B) derived from MRI data were qualitatively compared due to the discrepancy between the geometries.  173 
 174 
 175 
 176 
 177 
 178 
 179 
 180 
 181 
 182 
 183 
 184 
 185 
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Table 2. The electrophysiology of the heart was simulated for different pacing protocols: Atrial, 186 
Biventricular (BiV), Right ventricle (RV), and Left ventricle (LV). The QRS duration for the ACUTE and 187 
CHRONIC models was calculated as the time it takes for the ventricles to be electrically activated. This 188 
was compared against the clinical QRSd measured from ECGs.  189 
 190 
* Clinical data not available 191 
Model Limitations 192 
The biomechanical models of the heart were created based on a considerable and detailed clinical data, 193 
however, there was still insufficient information to fully characterize the models, therefore assumptions 194 
and simplifications had to be made.  195 
Case time pacing Simulated QRSd (ms) Clinical QRSd(ms) 
Case 1 
ACUTE Atrial 151.5 152 
ACUTE BiV 112.1 * 
CHRONIC Atrial 180.5 * 
CHRONIC BiV 141.4 141 
CHRONIC RV 166.6 * 
CHRONIC LV 166.8 * 
Case 2 
ACUTE Atrial 176.0 176 
ACUTE BiV 149.1 * 
CHRONIC Atrial 190.4 190 
CHRONIC BiV 151.7 157 
CHRONIC RV 190.2 183 
CHRONIC LV 151.9 162 
Case 3 
ACUTE Atrial 126.2 126 
ACUTE BiV 89.8 * 
CHRONIC Atrial 188.2 188 
CHRONIC BiV 138.8 130 
CHRONIC RV 179.8 178 
CHRONIC LV 214.5 205 
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The microstructure of the cardiac tissue is an important factor in how the electrical activation spreads 196 
throughout the heart and the mechanical functioning of the heart. Common methods for determining 197 
the fiber orientation of the cardiac tissue have been through histology or diffusion tensor (DT) MRI. The 198 
majority of DT MRI cardiac studies have been performed on ex vivo hearts
22, 23
, though recently studies 199 
have been performed in-vivo with healthy human subjects
24, 25
. Lengthy acquisition times for DT MRI, 200 
low resolution and motion artifacts from heart motion and breathing are still challenges that need to be 201 
overcome before this method can be applied to clinical cases. In the absence of information regarding 202 
the orientation of the fibers in the tissue for the individual patient cases in this study, we have 203 
approximated the fiber orientation in the heart model by using a generic fiber model based on 204 
histological studies of canine and human data
10
. Earlier studies have shown similarities between the 205 
myofiber orientation between human and canine data
26
 and that the mechanics and electrophysiology 206 
models are robust to errors in minor perturbations of the fiber orientations.  207 
Another limitation of the models is that the regions of the heart were set to be either infarcted or 208 
normal based on contrast enhanced MRI. Within the regions classified as infarcted or normal, the 209 
mechanical and electrical model parameters were assumed to be homogeneous. However, regional 210 
heterogeneities have been found even across normal cardiac tissue, with the material properties varying 211 
across the heart transmurally, apical-basally, and between the ventricles and also across the septum, 212 
and it has been found that the degree of heterogeneity can increase within infarcted tissue. The 213 
heterogeneities within the viable and scar regions were not taken into account in the models as there is 214 
currently an incomplete understanding of how the material properties vary across the heart, particularly 215 
under pathological conditions. In addition, while it is possible within the model framework to simulate 216 
heterogeneous material properties across the model, the clinical data collected for the three patients 217 
was insufficient to accurately personalize heterogeneous parameters within the normal and infarct 218 
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regions. Therefore we have chosen to use a homogeneous simplification of the material properties 219 
within each region. 220 
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